Drugs / Fractional IPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT04504539 | Aug 2020 → May 2021 | — | Aga Khan University | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06748612 Comparator | Jan 2025 → Dec 2027 expected | poliomyelitis | International Centre for Diarrhoeal Disease Research, Bangladesh | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fractional IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04504539 ↗ |
| Known as | fIPV | “fIPV (fractional dose injectable polio vaccine)” NCT04504539 ↗ |
| Modality | Vaccine | “fIPV (fractional dose injectable polio vaccine)” NCT04504539 ↗ |